XOMA Limited (NASDAQ:XOMA)

CAPS Rating: 1 out of 5

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

Recs

0
Player Avatar jwray01 (99.62) Submitted: 8/15/2012 2:24:31 AM : Underperform Start Price: $3.06 XOMA Score: -7.65

stock spam

Featured Broker Partners


Advertisement